GT Biopharma (GTBP) Earnings Date & Reports

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GTBP is expected to report earnings to fall 74.24% to -8 cents per share on March 27

GT Biopharma GTBP Stock Earnings Reports

Q4'23

Est.

$-0.09

Q1'25

Beat

by $0.26

Q3'23

Beat

by $0.03

Q2'23

Beat

by $0.05

Q1'23

Beat

by $0.16

The last earnings report on May 15 showed earnings per share of -33 cents, beating the estimate of -58 cents. With 19.00K shares outstanding, the current market capitalization sits at 6.99M.

View a ticker or compare two or three

Compare

GTBP